Adequate reimbursement is crucial to support cost-effective rapid on-site cytopathology evaluations.
作者信息
Al-Abbadi Mousa A, Bloom Leonard I, Fatheree Lisa A, Haack Lori A, Minkowitz Gerald, Wilbur David C, Austin Marshall R
机构信息
James H. Quillen VA Medical Center, Department of Pathology, East Teneesee State University, Johnson City, USA.
出版信息
Cytojournal. 2010 Oct 18;7:22. doi: 10.4103/1742-6413.71740.
Abstract
摘要
相似文献
1
Adequate reimbursement is crucial to support cost-effective rapid on-site cytopathology evaluations.
Cytojournal. 2010 Oct 18;7:22. doi: 10.4103/1742-6413.71740.
2
Compensation crisis related to the onsite adequacy evaluation during FNA procedures-Urgent proactive input from cytopathology community is critical to establish appropriate reimbursement for CPT code 88172 (or its new counterpart if introduced in the future).
Cytojournal. 2010 Oct 18;7:23. doi: 10.4103/1742-6413.71741.
3
Results from the 2019 American Society of Cytopathology survey on rapid onsite evaluation (ROSE)-part 2: subjective views among the cytopathology community.
J Am Soc Cytopathol. 2020 Nov-Dec;9(6):570-578. doi: 10.1016/j.jasc.2020.06.010. Epub 2020 Jul 21.
4
[Cost-effectiveness of new drugs impacts reimbursement decision making but room for improvement].
Ned Tijdschr Geneeskd. 2010;154:A958.
5
Intraoperative and on-site cytopathology consultation: utilization, limitations, and value.
Semin Diagn Pathol. 2002 Nov;19(4):227-36.
6
Reimbursement and clinical guidance for pharmaceuticals in Sweden: do health-economic evaluations support decision making?
Eur J Health Econ. 2005 Sep;6(3):274-9. doi: 10.1007/s10198-005-0301-6.
7
Interobserver concordance for endoscopic ultrasonography-guided fine-needle aspiration on-site cytopathology.
Endosc Ultrasound. 2014 Apr;3(Suppl 1):S15.
8
[Relevance of pharmacoeconomic analyses to price and reimbursement decisions in Austria].
Wien Med Wochenschr. 2006 Dec;156(23-24):612-8. doi: 10.1007/s10354-006-0357-7.
9
Health economic evaluations in reimbursement decision making in the Netherlands: time to take it seriously?
Z Evid Fortbild Qual Gesundhwes. 2014;108(7):383-9. doi: 10.1016/j.zefq.2014.06.016. Epub 2014 Aug 12.
10
The 1990s--interface of cytopathology and new technology.
Diagn Cytopathol. 1992;8(3):205-7. doi: 10.1002/dc.2840080303.
引用本文的文献
1
Value of transbronchial needle aspiration combined with a rapid on-site evaluation of cytology in the diagnosis of pulmonary lesions.
Front Med (Lausanne). 2022 Oct 5;9:922239. doi: 10.3389/fmed.2022.922239. eCollection 2022.
2
Improving the results of pancreatic endoscopic ultrasound-guided fine needle aspiration in daily practice: keep it simple.
Endosc Int Open. 2015 Apr;3(2):E138-9. doi: 10.1055/s-0034-1391416. Epub 2015 Feb 11.
3
Authors attain comparable or slightly higher rates of citation publishing in an open access journal (CytoJournal) compared to traditional cytopathology journals - A five year (2007-2011) experience.
Cytojournal. 2014 Apr 29;11:10. doi: 10.4103/1742-6413.131739. eCollection 2014.
4
High-quality endoscopic ultrasound-guided fine needle aspiration tissue acquisition.
Adv Ther. 2014 Jul;31(7):696-707. doi: 10.1007/s12325-014-0129-5. Epub 2014 Jun 24.
5
Announcement of first time Cytojournal impact factor for 2012 coincides with Cytojournal decade celebration (2004-2013).
Cytojournal. 2013 Aug 30;10:18. doi: 10.4103/1742-6413.117359. eCollection 2013.
6
Utility of on-site evaluation of endobronchial ultrasound-guided transbronchial needle aspiration specimens.
Cytojournal. 2011;8:20. doi: 10.4103/1742-6413.90081. Epub 2011 Nov 21.
7
Compensation crisis related to the onsite adequacy evaluation during FNA procedures-Urgent proactive input from cytopathology community is critical to establish appropriate reimbursement for CPT code 88172 (or its new counterpart if introduced in the future).
Cytojournal. 2010 Oct 18;7:23. doi: 10.4103/1742-6413.71741.
本文引用的文献
1
Diagnostic difficulties and pitfalls in rapid on-site evaluation of endobronchial ultrasound guided fine needle aspiration.
Cytojournal. 2010 Jun 14;7:9. doi: 10.4103/1742-6413.64385.
2
Progression from on-site to point-of-care fine needle aspiration service: Opportunities and challenges.
Cytojournal. 2010 May 12;7:6. doi: 10.4103/1742-6413.63195.
3
Endoscopic ultrasound-guided fine-needle aspiration of solid pancreatic masses with rapid on-site cytological evaluation by endosonographers without attendance of cytopathologists.
J Gastroenterol. 2009;44(4):322-8. doi: 10.1007/s00535-009-0001-6. Epub 2009 Mar 10.
4
Reliability of gross visual assessment of specimen adequacy during EUS-guided FNA of pancreatic masses.
Gastrointest Endosc. 2009 Jun;69(7):1264-70. doi: 10.1016/j.gie.2008.08.030. Epub 2009 Feb 24.
5
Dynamic telecytopathology of on site rapid cytology diagnoses for pancreatic carcinoma.
Cytojournal. 2006 Dec 11;3:27. doi: 10.1186/1742-6413-3-27.
6
Endoscopic ultrasound-guided fine-needle aspiration. A cytopathologist's perspective.
Am J Clin Pathol. 2003 Sep;120(3):351-67. doi: 10.1309/MFRF-J0XY-JLN8-NVDP.
7
Diagnostic value and cost-effectiveness of on-site evaluation of fine-needle aspiration specimens: review of 5,688 cases.
Diagn Cytopathol. 2002 Jul;27(1):1-4. doi: 10.1002/dc.10065.
8
Immediate on-site interpretation of fine-needle aspiration smears: a cost and compensation analysis.
Cancer. 2001 Oct 25;93(5):319-22. doi: 10.1002/cncr.9046.
9
Comparison of the costs of fine-needle aspiration and open surgical biopsy as methods for obtaining a pathologic diagnosis.
Cancer. 1997 Feb 25;81(1):51-6. doi: 10.1002/(sici)1097-0142(19970225)81:1<51::aid-cncr11>3.0.co;2-b.
10
Needle aspiration of the breast.
Cancer. 1984 Feb 1;53(3 Suppl):671-6. doi: 10.1002/1097-0142(19840201)53:3+<671::aid-cncr2820531313>3.0.co;2-a.
Zotero 插件